China Home to $3.4 Billion in Pharmaceutical Intermediates Projects

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Plants for manufacturing pharmaceutical intermediates, the synthetic raw material for active pharmaceutical ingredients (API), are gathered around China's developed cities and provinces, including Beijing, Jiangsu, Shanghai and Zhejiang.

Industrial Info is tracking 89 active pharmaceutical intermediates projects in China, worth US$3.4 billion. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a full list of detailed project reports.

Click on the image at right for a breakdown of pharmaceutical intermediates projects in China, by the top five project types.

The highest-valued project is in Zhejiang Province: Apeloa Pharmaceutical Company Limited's US$108.9 million expansion at its Jinhua (Dongyang) API plant.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: LinkedIn.